To determine how an oncogenic tyrosine kinase disturbs cell cycle control we examined expression of cell cycle proteins and growth of ®broblasts reversibly transformed by a temperature sensitive mutant of v-Src (ts LA 29). ts LA 29 Rat-1 cells and normal Rat-1 cells had similar growth rates but the transformed cells traversed the G 1 phase of the cell cycle more rapidly and failed to exit cycle eciently in response to serum starvation and cell con¯uence. Cyclin D1 and cyclin E levels were not elevated in growing ts LA 29 Rat-1 cells and the abbreviated G 1 was further accelerated by overexpression of cyclin E. A fall in cyclin E and cyclin A dependent kinase activities in Rat-1 cells in response to inhibitory growth conditions was abrogated in ts LA 29 Rat-1 cells and correlated with lack of p27 accumulation or cyclin A down regulation, the latter due to sustained cyclin A promoter activity. The expression of p27 mRNA was lower in ts LA 29 Rat-1 cells than Rat-1 cells and was elevated following v-Src inactivation concurrent with an increase in p27 promoter activity and temporary cell cycle exit. The suppression of mRNA or transcription is a novel way an oncoprotein can induce down regulation of p27 and contributes to the G 1 shortening and perturbed cell cycle regulation of the v-Src transformed cells.
Introduction
Neoplastic transformation is typi®ed by altered cell behaviour and disregulation of the cell cycle. In normal cells, progress through the cycle is controlled by the sequential activity of a family of serine/threonine kinases, the cyclin dependent kinases (CDKs) (Nigg, 1995; Pines and Hunter, 1995; Sherr, 1994) . These are so called because they need association with a cyclin subunit both for activity and to determine speci®city for their substrates, the eectors of cell cycle progression such as the retinoblastoma protein, pRb (Weinberg, 1995) . Three types of cyclin/CDK complexes are required for completion of the G 1 phase; cyclin D1/CDK4/6, cyclin E/CDK2 and cyclin A/ CDK2 (Ohtsubo et al., 1995; Baldin et al., 1993; Pagano et al., 1992 Pagano et al., , 1993 Quelle et al., 1993; Tsai et al., 1993; Winston and Pledger, 1993; Elledge et al., 1992; Matsushime et al., 1992; Won et al., 1992; Girard et al., 1991) . The mechanism of CDK regulation is complex but important components comprise two classes of CDK inhibitory proteins (CKIs), the CIP-KIP family, p21, p27 and p57 and the INK4 family, p15, p16, p18 and p19 (Elledge et al., 1996; Sherr and Roberts, 1995) .
Evidence is accumulating that overexpression of CDK complex components, or deletion or mutation of CKIs, contribute to neoplasia in vivo (Kamb, 1995; Pines, 1995) Thus, cyclin D1 was ®rst identi®ed as the PRAD1 oncoprotein (Motokura et al., 1991; Motokura and Arnold, 1993) and overexpression of G 1 cyclins can shorten the G 1 phase and reduce growth factor requirements for cells in vitro (Resnitzky and Reed, 1995; Resnitzky et al., 1994; Wimmel et al., 1994; Ohtsubo and Roberts, 1993; Quelle et al., 1993) . Conversely, deletion of the gene encoding pl6 is one of the most frequent occurrences in human tumours (Kamb, 1995; Kamb et al., 1994) and, although few deletions or mutations in the gene encoding p27 have been found (Spirin et al., 1996) , mice with germline deletions of this gene suer multi-organ hyperplasia and gigantism (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Consonant with this, p27 overexpression causes cell cycle arrest and its inhibition suppresses cellular quiescence (Coats et al., 1996; Polyak et al., 1994b; Toyoshima and Hunter, 1994) .
Many oncoproteins have their primary site of action outside the nucleus but can, nonetheless, perturb cell cycle control. We have shown that the membrane associated, non-receptor tyrosine kinase oncoprotein, v-Src, is a powerful mitogen, capable of stimulating quiescent cells out of G 0 but also required for cells to complete G 1 in the absence of mitogenic growth factors (Wyke et al., 1993) . Integrity of the mitogen-activated protein (MAP) kinase pathway (Wyke et al., 1995) and of the AP-1 transcription factor (Frame et al., 1994) are essential to v-Src induced cell cycle transit but, as with other non-nuclear oncoproteins, the details of how v-Src acts as a mitogen remain obscure.
We report here a further examination of the mitogenic action of v-Src, exploiting the rapidly reversible activity of the temperature sensitive v-Src mutant, ts LA 29, in Rat-1 cells (Welham and Wyke, 1988; White and Weber, 1988) . We found that v-Src transformed cells traversed G 1 more rapidly and did not exit cycle eciently in response to inhibitory stimuli. Therefore we examined the expression of cell cycle regulators and found that v-Src transformation did not aect the levels of cyclin D1 and cyclin E but acted in a fashion complementary with these two regulators. Under growth inhibitory conditions, accumulation of the CDK inhibitor, p27, was prevented in v-Src transformed cells while levels of cyclin A, CDK2 and the cyclin A and cyclin E associated kinase activities were maintained. The eect of v-Src on cyclin A and p27 levels were mediated by altered regulation of the mRNA in part through altered promoter activities, eects which were reversed following inactivation of the v-Src activity.
Results
Expression of v-Src decreased the proportion of cells in the G 0 /G 1 phase Rat-1 ®broblasts expressing a temperature sensitive (ts) mutant of Rous sarcoma virus (ts LA 29 Rat-1) are transformed at the permissive temperature (358) and display normal morphology and behaviour at the restrictive temperature (39.58) (Welham et al., 1990; White and Weber, 1988) . To study the eect of v-Src on cell cycle control, we compared the growth characteristics of ts LA 29 Rat-1 with non transfected Rat-1 cells at both temperatures in medium containing 5% serum. At densities below con¯uence Rat-1 and ts LA 29 Rat-1 cells increased in number at the same rate at 358C but under restrictive conditions the growth of ts LA 29 Rat-1 was impaired relative to Rat-1 ( Figure  1a) .
The growth rate of the two cell lines may indeed be the same at permissive temperature or in one line a higher growth rate may be balanced by a higher rate of cell death. We analysed cells growing exponentially at 358C by propidium iodide staining and¯ow cytometry ( Figure 1b ) and found no evidence of cells with a sub-G 1 DNA content (indicative of apoptotic cells) in either cell line. However this analysis did show that the nuclei of ts LA 29 Rat-1 were more uniform in size and a greater proportion had more than 2n DNA content compared with the Rat-1 cells. These dierences were readily reversed following shift of ts LA 29 Rat-1 cells to the restrictive temperature (data not shown). The cell cycle distribution was determined for the cells which had a normal pattern of DNA content (boxed in Figure 1b ) and in this population the proportion of cells in the G 0 /G 1 phase was signi®cantly reduced in ts LA 29 Rat-1 cells, with a compensatory increase in the proportion of S-phase cells (Figure 1c) .
Expression of v-Src reduces the length of the G 1 phase
Under optimal growth conditions 97% of normal and transformed cells entered S-phase over a 24 h period, as judged by bromodeoxyuridine (BrdU) incorporation (data not shown). Thus the G 0 /G 1 population shown in Figure 1c , mainly comprised G 1 cells which, combined with the data showing similar growth rates at the permissive temperature (Figure 1a) , suggests that the transformed cells traverse G 1 faster. In order to compare transit through G 1 directly we allowed a population of exponentially growing Rat-1 or ts LA 29 Rat-1 cells to incorporate BrdU for l h. Since cells which incorporated BrdU were in S-phase at the time of labelling, we harvested cells at intervals after replacement of the medium to monitor the progress of the labelled cells through subsequent phases of the cell cycle. We identi®ed the labelled cells by immunostaining and determined their cell cycle position by propidium iodide staining as described in Materials and methods. The percentage in each phase of the cell cycle at times after the pulse is shown in Figure 2a . Most cells progressed to G 2 /M or G 1 phases by 8 h although the Rat-1 cells progressed slightly faster with 8% more in G 1 . By 16 h the ts LA 29 Rat-1 cells had overtaken the Rat-1 cells with 27% more in the next S-phase, demonstrating that v-Src expression accelerated progress of some cells through the G 1 phase while slightly slowing their progress through S-phase.
Expression of v-Src prevents eective cell cycle exit v-Src transformed cells are able to grow in the absence of mitogens and when con¯uent (Jove and Hanafusa, 1987) . Therefore we compared the eect of low serum or con¯uence on the cell cycle distribution of Rat-1 and ts LA 29 Rat-1 cells. We harvested cells 24 h after transfer to low serum conditions or following growth to con¯uence in normal growth medium for analysis of cell cycle position by propidium iodide staining and ow cytometry. An example of one experiment is shown in Figure 2b . Normal Rat-1 cells accumulated in G 0 /G 1 at con¯uence or 24 h after shift to low serum conditions. In contrast when v-Src transformed cells were grown to con¯uence a signi®cant proportion remained in cycle ( Figure 2b ) and they reached densities ®ve times those of normal cells (not shown). Moreover, v-Src transformed cells remained distributed throughout the cell cycle 24 h after shift to low serum, although the portion in S-phase fell to 18% after 2 days at which point there was no further increase in cell number (not shown). We could not detect an increase in cells with a sub-G 1 DNA content indicative of apoptotic cells (not shown) but we did not check for cell loss by other methods. Thus, v-Src transformed cells remain distributed throughout the cell cycle under inhibitory conditions, indicating impaired cell cycle exit even when continued healthy multiplication is precluded.
Enforced overexpression of G 1 cyclins in cells expressing v-Src can further shorten the G 1 phase of v-Src transformed cells
To investigate the mechanisms for these cell cycle eects of v-Src, we ®rst examined the G 1 cyclins, since overexpression of cyclin D1 or cyclin E shortens G 1 and reduces growth factor requirements in Rat-1 (Resnitzky et al., 1994) and other mammalian ®broblasts (Ohtsubo and Roberts, 1993; Quelle et al., 1993) . We compared the levels of cyclin expression by immunoblotting using proteins extracted from exponentially growing Rat-1 and ts LA 29 Rat-1 cells. v-Src transformation did not lead to increased cyclin D1 or cyclin E expression ( Figure 3a ) and the slight decrease observed may re¯ect the reduced numbers of transformed cells in G 0 /G 1 . To determine whether vSrc transformation by-passed cyclin D1 or cyclin E dependent regulation of G 0 /G 1 we investigated whether overexpression of either cyclin would further shorten the abbreviated G 1 . We generated a number of clones of ts LA 29 Rat-1 showing regulated expression of cyclin D1 or cyclin E, using the Stratagene Lacswitch TM inducible mammalian expression system. As shown in Figure 3b , addition of the inducer, isopropyl-b-Dthiogalactoside, (IPTG) increased the expression of the Figure 3 The expression of cyclin D1 and cyclin E in Rat-1 and ts LA 29 Rat-1 cells and the eect of inducible expression of cyclins on the cell cycle of ts LA 29 Rat-1 cells. (a) Proteins were extracted from asynchronously growing Rat-1 and ts LA 29 Rat-1 at the permissive temperature and analysed by immunoblotting using antibodies able to detect cyclin D1 or cyclin E. (b) Induction of cyclin protein in clones that express cyclin E (E2), cyclin D1 (D5) or empty vector control (C2). Cells were harvested at intervals (h) following addition of 1 mM IPTG to asynchronous cultures at the permissive temperature. Proteins were analysed by immunoblotting using antibodies against cyclin D1 (D5) or cyclin E (E2 and C2). (c) Asynchronous ts LA 29 cells that inducibly express cyclin D1 or cyclin E, or cells containing the empty vector, were grown in the presence or absence of IPTG. Propidium iodide staining and¯ow cytometry were used to determine the percentage of cells in each phase of the cell cycle. The dierence was calculated as the induced (+ IPTG) minus the uninduced (7 IPTG). 14 samples from four dierent clones containing cyclin E plasmid, 16 samples from three dierent clones containing cyclin D1 plasmid or 11 samples from three dierent clones containing control plasmid were analysed. Samples marked with an asterisk are statistically signi®cant when compared with controls (a50.005), calculated using a two tailed t-test for small samples comparing the mean dierence in the cyclin D1 or cyclin E clones with those of the control clones. respective cyclins within 4 h, with no eect on control clones bearing the plasmid alone. To study how the cell cycle was in¯uenced by cyclin overexpression several inducible and control cell lines were grown at permissive temperature in the presence or absence of IPTG for 72 h. Figure 3c , shows that overexpression of cyclin E in four cell lines signi®cantly reduced the proportion of cells in G 1 by a mean of 10.5% which was compensated by a comparable increase in the proportion in S-phase. The eect of cyclin D1 overexpression in three cell lines was less marked but still statistically signi®cant when compared with control cells containing plasmid alone, which showed no cell cycle redistribution. We demonstrated accelerated G 1 transit in ts LA 29 Rat-1 cells overexpressing cyclins by comparing traverse of the cell cycle, as described previously (Figure 2a ), in the presence and absence of inducer (IPTG). We reproduced results using two clones expressing each cyclin and two control clones and a representative experiment is shown in Figure 3d . Transfected clones of all types cycled slightly more slowly than parental ts LA 29 Rat-1 cells in the absence of inducer, possibly due to the selection procedure, (compare Figure 3d with Figure 2a ) and induction of cyclin D1 had little eect on this pattern ( Figure 3d) . Cyclin E overexpression, however, slowed the completion of S-phase and at 8 h after labelling 32% more of the induced cells were still in S-phase (compare arrows r and s in Figure 3d ), with a comparable reduction in the combined proportions in G 2 /M and G 1 /G 0 . These induced cells nonetheless traversed G 1 more rapidly and, by 20 h after pulse labelling, they had overtaken the uninduced cells, with 9% more of them in the next S-phase ( Figure 3d , compare arrows t and u). Thus, although overexpression of cyclin D1 had only a minor eect on the cycling of cells expressing v-Src, overexpression of cyclin E signi®cantly further retarded S-phase and accelerated G 1 . This suggests that cyclin E is limiting for G 1 transit in growing ts LA 29 Rat-1 cells and that v-Src exerts its eects through other cell cycle regulators.
p27 expression is lower in v-Src transformed cells and does not accumulate in response to inhibitory conditions
To examine the eect of v-Src on expression of other proteins involved in regulation of the G 1 phase we harvested Rat-1 and ts LA 29 Rat-1 cells in normal growth medium and either 24 h after shift to low serum conditions or upon reaching con¯uence. We examined the expression of cell cycle proteins in extracts from the cells by immunoblotting using speci®c antibodies. We observed striking eects of vSrc in (1) preventing down regulation of cyclin A and CDK2 levels under growth inhibitory conditions and in (2) reducing levels of the CDK inhibitor p27 in growing cells and preventing its accumulation under inhibitory conditions (Figure 4a ).
The eect of v-Src transformation on p27, CDK2 and cyclin A suggested that v-Src may aect CDK2 associated kinase activity. Since pRb is phosphorylated by cyclin dependent kinases during the G 1 phase we examined the extent of pRb phosphorylation by immunoblotting and showed that v-Src transformation reduced the shift from hyper to hypophosphorylated pRb after growth in low serum conditions or at con¯uence (Figure 4b) . A number of cyclin dependent kinases can phosphorylate pRb and to assess directly whether v-Src aected CDK2 associated kinase activities we immunoprecipitated the CDK2, cyclin E or cyclin A associated kinases from the cells and measured their activity in vitro. Figure 4c shows that vSrc induced a small increase in cyclin E and cyclin A associated activities in growing cells and prevented their inactivation under inhibitory conditions, the same was found with immunoprecipitated CDK2 (data not shown). Thus the shortened G 1 phase in v-Src transformed cells is associated with reduced levels of p27 expression and increased activity of CDK2 associated kinases. The failure of v-Src transformed cells to accumulate in G 0 /G 1 under inhibitory conditions correlates with sustained expression of cyclin A and CDK2, delayed dephosphorylation of pRb and sustained activation of CDK2 associated kinase activity.
The expression of cyclin A and p27 in v-Src transformed cells is controlled at the transcriptional level
Our results indicate that v-Src transformation disrupts the normal regulation of cyclin A and p27 expression. To investigate the mechanism of their regulation by vSrc we exploited the reversibility of v-Src activity in the ts LA 29 Rat-1 cells and examined the levels of cyclin A and p27 mRNAs in Rat-1 and ts LA 29 Rat-1 cells grown under dierent conditions. Under low serum conditions cyclin A mRNA was down regulated in Rat-1 cells but not in ts LA 29 Rat-1 cells ( Figure  5a ), paralleling the observations on protein levels (Figure 4a ). Surprisingly however, cyclin A mRNA was down regulated 16 h after inactivation of v-Src in normal growth medium. In contrast there was a very modest accumulation of p27 mRNA in normal cells under low serum conditions (Figure 5a ) which was not sucient to explain the accumulation of p27 protein (Figure 4a) , however, the level of p27 mRNA was lower in the v-Src transformed cells and accumulated strongly when v-Src was inactivated for 16 h ( Figure  5a ). These changes in mRNA were sucient to explain the changes in the levels of p27 protein ( Figure 4a ) and we conclude that v-Src transformation in¯uenced cyclin A and p27 expression by altering the mRNA levels.
To investigate whether the changes in mRNA levels were due to changes in transcription we utilized an assay system where the promoters of p27 (Kwon et al., 1996) or cyclin A (Kramer et al., 1996) were linked to a luciferase reporter gene. We introduced the reporter plasmids into Rat-1 or ts LA 29 Rat-1 cells by transient transfections in normal growth medium then transferred the cells to dierent growth conditions for 24 h prior to harvesting and assaying luciferase activity in cell extracts. These results were reproduced in three repeat experiments and a representative experiment is shown in Figure 5b . We found that all promoters produced higher levels of luciferase activity in Rat-1 cells compared with ts LA 29 Rat-1 cells, which was partly explained by dierences in the transfectability of these two cell types. Therefore we did not attempt to compare Rat-1 to ts LA 29 Rat-1 cells and the results in Figure 5b are presented as the percent activity compared to the high serum control for each cell type. When grown under low serum conditions there was a tenfold decrease in the activity of the cyclin A promoter in the Rat-1 cells whereas there was no decrease in the ts LA 29 Rat-1 cells. In contrast there was a 20-fold decrease in the cyclin A promoter activity following inactivation of v-Src for 24 h ( Figure  4b) . In both the Rat-1 cells and ts LA 29 Rat-1 cells the p27 promoter was not signi®cantly aected by growth in low serum conditions, however, the small (1.2-fold) increase in the p27 promoter activity following inactivation of v-Src for 24 h was both signi®cant and reproducible. Although the change in p27 promoter activity following v-Src inactivation is smaller than the change in p27 mRNA two other promoters (SV40 promoter/enhancer and minimal Herpes Simplex Virus thymidine kinase) showed lower levels of transcription following v-Src inactivation. Therefore we conclude that v-Src transformation disrupts the regulation of cyclin A expression under low serum conditions through changes in cyclin A promoter activity. The increase in p27 mRNA levels following inactivation of v-Src is at least partly mediated through changes in promoter activity and indicates that v-Src transformation suppresses p27 promoter activity. The reduction in p27 mRNA and promoter activity by v-Src transformation is not simply a re¯ection of cell cycle perturbation since p27 promoter activity did not increase in Rat-1 cells induced to exit the cell cycle. This suggests that p27 alterations contribute to the eects of v-Src transformation on the cell cycle rather than being a consequence of them.
v-Src transformed cells transiently exit cycle following inactivation of v-Src
Since p27 was down regulated in v-Src transformed cells, its induction following v-Src inactivation was not surprising. We were surprised, however, by the down regulation of cyclin A mRNA and promoter activity when v-Src was switched o. Although ts LA 29 Rat-1 cells proliferate at the restrictive temperature ( Figure 1a ) it is possible that the changes in cyclin A expression may result from transient cell cycle exit following v-Src inactivation. Therefore we investigated the cell cycle distribution of ts LA 29 Rat-1 cells harvested at intervals following shift to restrictive conditions. Figure 6a shows that inactivation of v-Src led to rapid exit from the cell cycle and accumulation in G 0 /G 1 . We found that ts LA 29 vSrc transformed NIH3T3 ®broblasts similarly exited cycle transiently upon inactivation of v-Src but normal Rat-1 and NIH3T3 cells did not show this behaviour upon shift to the restrictive temperature (data not shown).
To characterise further the eect of v-Src inactivation on cell cycle regulators we extracted proteins from ts LA 29 Rat-1 cells harvested at intervals after shift to restrictive conditions. Immunoblot analysis (Figure 6b) shows that cyclin A was strongly down regulated by 16 h, while p27 accumulated which is in agreement with the regulation of the respective mRNAs and promoter regions. In addition there was a slight decrease in the level of cyclin E and a transient decline in cyclin D1. The later re-expression of cyclin D1 may be an early event in the resumption of cell cycling which occurs after 48 h. The rise in p27 and fall in cyclin A and cyclin E suggests a fall in the activities of associated kinases and this was also suggested by the decrease in hyperphosphorylated pRb (Figure 6c ). We measured the kinase activities associated with cyclin E and cyclin A directly using an in vitro assay (Figure 6d ) and found that the kinase activities fell between 1 and Figure 5 The expression of p27 and cyclin A mRNA and the associated promoter activities. (a) mRNA levels were determined by Northern blotting using probes for cyclin A or p27 using RNA extracted from Rat-1 or ts LA 29 Rat-1 cells incubated in normal growth medium (high serum), after 16 h in medium containing 0.2% serum (low serum) or 16 h after shift to the restrictive temperature in normal growth medium (src o high serum). (b) The promoter activity was measured using a luciferase reporter gene linked to the cyclin A or p27 promoter region. Cells were transfected in high serum at the permissive temperature and 6 h later either incubated in normal growth medium (high serum), in medium containing 0.2% serum (low serum), or shifted to the restrictive temperature in normal growth medium (src o high serum) and harvested 24 h later. The luciferase activity was normalised for protein concentration and is expressed as a percentage of the activity in high serum for each cell type (src on for ts LA 29 Rat-1). The results shown are representative of three independent experiments and the means+s.d. are from three transfections for each dierent condition v-Src transformation disrupts regulation of p27 D Johnson et al 4 h after inactivation of v-Src strongly concomitant with the increase in p27 expression and fall in pRb phosphorylation. These results show that the increase in p27 expression following inactivation of v-Src correlates with cell cycle exit and a fall in activity of cyclin dependent kinases.
Discussion

v-Src transformation perturbs the cycle of growing cells
We show here that v-Src aects the cycle of cells that are growing exponentially. It has two eects, a clear shortening of the G 0 /G 1 phase and an apparent lengthening of S-phase, with G 2 /M phases being unchanged (Figure 2a) . Given the shortening of G 0 / G 1 , S-phase extension is also implicit in the similarity of Rat-1 and ts LA 29 Rat-1 doubling times ( Figure  1a) . The presence of a ts LA 29 Rat-1 population with more than diploid DNA content (Figure 1b) suggests that v-Src perturbs DNA synthesis or mitosis generating a population of hyper diploid cells but the mechanism has not been investigated.
The v-Src-induced shortening of G 1 phase and the further shortening by cyclin E overexpression are clearly demonstrated whilst the similar eect of cyclin D1 overexpression, although statistically signi®cant, is quantitatively minor (Figure 3 ). Thus in v-Src transformed cells described here and in normal Rat-1 cells described previously (Resnitzky and Reed, 1995) cyclin E overexpression had more eect on G 1 progression in exponential growth than did cyclin D1, suggesting that the dierential response to these cyclins is not a result of v-Src transformation. Since overexpression of cyclin E and v-Src were additive in growing cells, the complementary role of v-Src may be mediated by enhancement of cyclin E or cyclin A associated activities resulting from the decreased expression of p27. Suppression of p27 levels by antisense oligonucleotides has been shown previously to shorten G 1 (Coats et al., 1996) .
v-Src transformation and cell cycle exit
Unlike the Rat-1 cells which accumulate in G 0 /G 1 , vSrc transformed cells remained distributed throughout the cell cycle when deprived of serum growth factors or grown to con¯uence (Figure 2b ). In contrast they accumulated in G 0 /G 1 when the oncogene was inactivated (Figure 6 ). The surprising temporary exit from the cell cycle following v-Src inactivation in the presence of serum growth factors may re¯ect another inhibitory environment. Cells transformed by v-Src display altered cell adhesions and cytoskeleton, possibly comparable in eect to anchorage deprivation (Fang et al., 1996) . While v-Src may allow cells in this state to continue cycling, in normal cells anchorage deprivation would be growth inhibitory. Normal cytoskeletal structures and cell adhesions are not restored for some hours after inactivating v-Src and cell cycle exit may be triggered by the abnormal adhesions.
Cell cycle exit following inactivation of v-Src, or when normal Rat-1 were deprived of serum, was accompanied by accumulation of p27, decreased transcription of cyclin A, inactivation of cyclin E and cyclin A associated kinase activities and decreased phosphorylation of pRb (Figures 4 and 6) . Cell cycle exit could result from increased p27 expression since in many cell types p27 overexpression was sucient to induce cell cycle exit (Polyak et al., 1994b) , while in some cell types inhibiting p27 expression prevented it (Coats et al., 1996) . The decreased transcription of cyclin A and fall in cyclin E and cyclin A associated kinase activities could be a consequence of the rise in p27 expression since others have reported that p27 inactivated cyclin E dependent kinases (Polyak et al., 1994a and b; Toyoshima and Hunter, 1994) and that p27 overexpression blocked cyclin E dependent transactivation of cyclin A expression (Zerfass-Thome et al., 1997). Conversely inactivation of cyclin E dependent kinases by an unknown mechanism could lead to accumulation of p27 since cyclin E dependent kinases phosphorylate p27 and trigger its destruction by the ubiquitin pathway (Shea et al., 1997) . However cyclin E overexpression does not prevent cell cycle exit, (Ohtsubo and Roberts, 1993) and data not shown, but renders cells less dependent on growth factors (Ohtsubo and Roberts, 1993) , therefore cell cycle exit does not simply result from the titration of cyclin E dependent kinases by p27. It is more likely that p27 plays a contributory role along with other processes which inactivate cyclin E dependent kinase activity and that cell cycle exit is controlled by a programme of events which are interdependent. We show here that v-Src alters the regulation of the programme of events leading to cell cycle exit and dissecting the contribution made by each component will require further experimentation. Our preliminary results show that inducible overexpression of p27 in vSrc transformed cells caused redistribution of growing cells with an increased proportion in G 0 /G 1 and a compensatory decrease in S-phase (our unpublished results). We have not tested the eect of increased p27 on the ability of the transformed cells to remain distributed through the cycle under inhibitory conditions. Although the ts LA 29 Rat-1 cells remained distributed throughout the cell cycle after 2 days in low serum conditions they did not increase in number. This inability to grow may be related to the decrease in pRb phosphorylation (Figure 4b and data not shown), which occurs even although CDK2 kinase activities remain high (Figure 4c ). We are checking whether an inhibitor apart from p27 targets other cyclin dependent kinases that are required for pRb phosphorylation. We have not investigated whether the cells arrest at dierent stages of the cell cycle or whether the lack of growth is due to an increase in cell death. Although we could not detect an increase in the number of apoptotic cells, the cells could be in a pre-apoptotic state, since inactivation of v-Src in low serum conditions caused the cells to enter the apoptotic programme within a few hours (our unpublished results).
Reduced expression of p27 in v-Src transformed cells
The levels of p27 mRNA were lower in the transformed cells than the normal cells and this was reversible following inactivation of the oncoprotein (Figure 5a ). The activity of the p27 promoter was also increased by the inactivation of v-Src suggesting that the decreased expression in v-Src transformed cells results partly from reduced transcription (Figure 5b ). Down regulation of p27 mRNA and transcription is probably not a consequence of the changes in the cell cycle distribution induced by v-Src since, unlike the protein levels, p27 mRNA has been reported not to vary during the cell cycle (Polyak et al., 1994b) and no potential binding sites for E2F, an important cell cycle regulated transcription factor, were found in the p27 promoter (Kwon et al., l996) . The regulation of p27 mRNA is unusual, p27 is more commonly regulated by changes in synthesis and degradation of the protein (Millard et al., 1997; Shea et al., 1997; Hengst and Reed, 1996; Pagano et al., 1995) . However, p27 transcription is down regulated during the proliferative response of T-lymphocytes (Schulze et al., 1995; Firpo et al., 1994) in which the Src family kinase Lck is known to play a role (Molina et al., 1992) . It would be interesting to determine whether Lck activity is required for this down regulation of p27 transcription.
Low levels of p27 expression correlate with poor prognosis in tumours (Catzavelos et al., 1997; Fredersdorf et al., 1997; Loda et al., 1997; Porter et al., 1997; Steeg and Abrams, 1997) especially in combination with high levels of cyclin E (Porter et al., 1997) however, p27 is rarely inactivated by deletion or mutation (Spirin et al., 1996) but the levels are reduced by increased proteolysis (Loda et al., 1997) . The importance of p27 in tumours is emphasized by the fact that it is inactivated by the oncogenic products of a number of tumour viruses. Myc can overcome p27 induced cell cycle arrest (Vlach et al., 1996) and can dissociate p27 from cyclin E/CDK2 complexes (Steiner et al., 1995) or prevent association of p27 with newly synthesized cyclin E (Perez-Roger et al., l997). Similarly adenovirus E1A and Human papillomavirus HPV-16 E7 both bind p27 and displace it from cyclin E/CDK2 complexes (Mal et al., 1996; Zerfass-Thome et al., 1996) , in particular the low risk HPV-11 E7 has a lower anity for p27 than E7 from the high risk HPV-16 suggesting an important role for this interaction in tumorigenesis (Zerfass- Thome et al., 1996) . We show here that v-Src transformation also induces p27 down regulation through changes in the promoter activity and the mRNA.
In conclusion, this investigation shows that v-Src transformation reduces the level of p27 mRNA transcription and, in response to inhibitory stimuli, prevents p27 accumulation, cyclin A down regulation, inactivation of cyclin E and cyclin A associated kinases, pRb dephosphorylation and cellular quiescence. Regulating transcription and mRNA is a novel way in which an oncogene can aect p27 activity. Investigating the mechanisms by which v-Src aects p27 transcription and how this contributes to the altered growth control of the transformed cells will be important in understanding how oncogenes inhibit cellular quiescence. It also allows us to concentrate on particular cell cycle regulators aected by v-Src when investigating which pathways activated by v-Src are involved in cell cycle regulation. This could lead to novel pathways of cell cycle disruption from the cell periphery and could lead to new ways of manipulating p27 expression and the behaviour of tumour cells in vivo.
Materials and methods
Cell culture, growth rate and cell cycle analysis of growing cells
Rat-1 cells and ts LA 29 Rat-1 cells (White and Weber, 1988) were maintained in Dulbecco's modi®ed Eagle medium with 5% new born calf serum (NBCS), 1 mM Sodium pyruvate, 2 mM L-Glutamine, 50 mg/ml streptomyv-Src transformation disrupts regulation of p27 D Johnson et al cin, 50 units/ml penicillin at 358C. For growth rate determinations, 2610 5 cells seeded in 100 mm dishes were fed and counted daily for 4 days using a Coulter counter. For analysis of cell cycle distribution 1.25610 6 cells were seeded in a T175¯ask and grow for 4 days until 50% con¯uent. 10 mM BrdU was added and cells were incubated in the dark for 1 h prior to harvest. For analysis of cell cycle distribution in lines capable of cyclin D1 or cyclin E expression 3610 5 cells were plated in 100 mm dishes in the presence or absence of inducer (1 mM isopropyl-b-DThiogalactoside [IPTG] ), fed after 48 h and harvested at 72 h. For the pulse-chase experiments 0.75610 5 cells were seeded in 100 mm dishes and fed after 48 h. Lines capable of cyclin D1 or cyclin E expression were plated in the presence or absence of inducer. After a further 48 h, 10 mM BrdU was added for 1 h and, after washing twice to remove the BrdU, the cells were grown in conditioned medium from replicate plates until harvested. For growth under inhibitory conditions 2610 5 cells were seeded in 100 mm dishes. They were fed daily and after 72 h some were harvested (sub-con¯uent, high serum), some were fed with medium containing 0.2% serum and harvested 24 h later (low serum) while others were fed daily with medium containing 5% serum and harvested at con¯uence (con¯uent). For the temperature shift experiment 2610 5 ts LA 29 Rat-1 cells were seeded in 100 mm dishes, fed every 24 h and after 48 to 72 h shifted to 39.58C for intervals until harvested.
BrdU immunostaining and¯ow cytometry
Cells were harvested by trypsinizing and resuspended in growth medium. They were collected by centrifugation at 1 000 g for 5 min, washed in 1 ml ice cold PBS and resuspended in 0.1 ml PBS. The cells were ®xed at 08C for 1 h or 48C overnight in 1 ml ice cold 70% ethanol, spun and resuspended in 0.5 ml normal saline. 0.5 ml 4N HCl was added while vortexing and the cell suspension was left for 15 min at room temperature. The cells were washed three times in PBT (PBS, 0.5% BSA, 0.1% Tween-20), incubated for 30 min at room temperature in a solution of mouse anti-BrdU (1 : 40 in PBT) (DAKO Ltd, Bucks, UK. Product code M0744), spun after addition of 1 ml of PBT and incubated with¯uorescein-conjugated goat anti-mouse antibody (1 : 40 in PBT) (Sigma, Product code F-0257) for 30 min at room temperature. 1 ml of PBT was added, the cells were washed once with 1 ml PBT, resuspended in 0.3 ml PBS containing 10 mg/ml propidium iodide and analysed by two parameter¯ow cytometry using the FACscan (Becton Dickinson).
Propidium iodide staining and¯ow cytometry
Cells were harvested, ®xed in ethanol (as described above) and resuspended in 0.3 ml PBS containing 10 mg/ml propidium iodide and 250 mg/ml DNAse-free RNAse (Promega). To determine the cell cycle distribution by propidium iodide staining, data collected from the FACscan were analysed using ModFit LT for Macintosh (Becton Dickinson Immunocytometry systems) with the F_DIP_N3.MOD model. A gated population of single diploid cells was analysed.
Generation of IPTG-inducible cyclin D1 or E-expressing cell lines using the Lac-Switch TM inducible expression system
Five mg of the plasmid p3'SS (Stratagene), containing the Lac I repressor gene and the hygromycin resistance gene, was transfected into 5610 5 cells in a 60 mm plate using DOTAP (Boehringer Mannheim). Colonies representing a clonal population of transfected cells were selected at 358C in the presence of 200 mg/ml hygromycin B (Boehringer Mannheim) and were tested for expression of the Lac repressor protein by isolation of RNA and Northern analysis using a Lac repressor probe (a 1160 base pair BglII to StuI fragment from p3'SS containing the LacIgene) or immunostaining on coverslips with the Lac repressor antibody (Stratagene). Lac7 was the clone which showed highest levels of repressor RNA and protein.
The plasmids pOPI3cycE and pOPRSVcycE were generated by cloning a 1.9 kilo base pair (kb) Bam HI fragment encoding the entire Rat cyclin E cDNA from pcD2-rat cyclin E (gift from K Tamura, Osaka University, Japan) into the pOPI3CAT or pOPRSVICAT vectors (Stratagene). pOPI3cycDl and pOPRSVIcycD1 were generated by cloning a 1.3 kb EcoRI fragment containing the entire mouse cyclin D1 cDNA (gift of G Peters, ICRF, London, UK) into the pOPI3CAT or pOPRSVICAT vectors (Stratagene). The completed plasmids were checked by mapping with six dierent restriction endonucleases. Five mg control plasmid or plasmid containing cyclin E or cyclin D1 was transfected into Lac7 cells in a 60 mm plate. Clones were selected with 650 mg/ml active G418 at 358C and screened for the ability to express cyclin E or D1 mRNA following addition of 1 mM IPTG to the culture medium. Expression was analysed by Northern analysis using probes described which were able to detect both endogenous and induced cyclin D1 or cyclin E mRNA. Of 8 screened, we isolated four clones with inducible cyclin E and of 7 screened, three inducing cyclin D1. The clones were maintained in medium containing 200 mg/ml hygromycin B and 650 mg/ml active G418 at 358C or half these drug concentrations at 39.58C.
Western blot analysis
Cells were washed with PBS, lysed in buer containing 50 mM HEPES (N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulonic acid]) pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM DTT (dithiothreitol), 0.1% Tween 20, 10% glycerol, 1 mM NaF, 10 mg/ml leupeptin, 20 units/ ml aprotinin, 10 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 0.1 mM phenylmethylsulphonyl¯uoride and sonicated for 20 s. After a 5 min spin in a microcentrifuge the protein concentrations in the supernatants were determined using the micro BCA protein assay reagent kit (Pierce). 30 to 50 mg of cellular protein was separated by 10% polyacrylamide gel electrophoresis. For analysis of pRb protein, 7.5% polyacrylamide containing a ratio of acrylamide to bis-acrylamide 30 to 0.24 was used. Separated proteins were blotted onto nitrocellulose, blocked with 5% milk in 0.1 % Tween-20, incubated with primary antibody, washed and incubated with secondary antibody linked to horseradish peroxidase (HRP). Detection was by chemiluminescence (Amersham) and exposure to Fuji RX ®lm. Antibodies against CDK2 (M2), CDK4 (C-22) and cyclin E (M-20) were used at 1 : 500 (Santa Cruz Biotechnology). The cyclin D1 antibody was directed to the C-terminal peptide (287-3) and used at 1 : 3000 (gift from G Peters ICRF, London, UK). The pRb monoclonal antibody was used at 1 : 500 (Pharmingen G3-245). The p27 antibody was directed against full length His-tagged murine p27 and was used at 1 : 2000 dilution (gift from S Coats, Amgen, CA USA). HRP conjugated secondary antibodies were used at 1 : 5000 (Amersham).
Northern blot analysis
1610
7 cells were seeded in a T175¯ask in normal growth medium at 358C. They were fed after 24 h and after 48 h incubated in medium containing 5% or 0.2% serum at 358C or 39.58C for 16 h until harvest. RNA was extracted using RNAzol according to the manufacturer's instructions (Biotecx laboratories, Inc). The ®nal RNA pellet was resuspended in 50 ml distilled water and quantitated by v-Src transformation disrupts regulation of p27 D Johnson et al absorbance at 260 nm. 20 mg RNA was concentrated by vacuum drying and run on a 1% denaturing agarose gel. The RNA was transferred to Hybond-N nylon membranes (Amersharn) and bound by U.V. crosslinking. The blot was hybridized against 32 P-labelled DNA probes in a buer containing 0.25 M sodium phosphate pH 7.2, 7% sodium dodecyl sulphate (SDS), 1 mM EDTA. Hybridizations were performed overnight at 688C. The membranes were washed twice in 20 mM sodium phosphate pH 7.2, 1 mM EDTA, 5% SDS for 10 min and three times in 20 mM sodium phosphate pH 7.2, 1 mM EDTA, 1% SDS. The probes used were: a 1.3 kb EcoRI fragment containing the mouse cyclin D1 cDNA (gift from G Peters, ICRF, London, UK); a 1.9 kb Bam HI fragment containing the rat cyclin E cDNA from pcD2-Rat cyclin E (gift from K Tamura, Osaka University, Japan); a 1.2 kb EcoRI fragment containing mouse cyclin A2 (gift from M Carrington, Cambridge University, UK) and a 600 bp EcoRI fragment containing the coding region of human p27 (gift from Steve Coats, Amgen, CA, USA).
Luciferase assays
2.5610
5 Rat-1 or ts LA 29 Rat-1 cells were seeded in 60 mm dishes. After 24 h cells were transfected using DOTAP with 5 mg per plate of either pWT929 containing 7754 to +175 of the human cyclin A promoter region linked to a luciferase reporter gene (Kramer et al., 1996) (gift of William E Fahl, Wisconsin) or K4 containing 71609 to +178 of the murine p27 promoter region linked to a luciferase reporter gene (Kwon et al., 1996) (gift of Albert A Nordin, Baltimore). After 6 h the medium was replaced with medium containing 5% or 0.2% serum and the cells were incubated at 358C or 39.58C for a further 24 h until harvest. Cells were washed twice with PBS then lysed in 100 ml cell culture lysis reagent (Promega) per plate and scraped into microcentrifuge tubes. Lysates were spun for 5 s then 20 ml was transferred to a luminometer cuvette and the luciferase activity measured in a luminometer (Bio Orbit). The protein concentration in the cell lysate was determined using the micro BCA protein assay (Pierce) and luciferase activity was normalised for protein concentration.
Cyclin dependent kinase assays
2610
6 Rat-1 or ts LA 29 Rat-1 cells were seeded in 150 mm dishes. After 24 h medium containing either 5% or 0.2% serum was added and the cells were incubated for 24 h until harvest or transferred to 39.58C for various times prior to harvest. To obtain con¯uent cultures 4610 6 Rat-1 or 5610 6 ts LA 29 cells were seeded in 150 mm dishes and fed every 24 h for 72 h. Cells were harvested by washing twice in PBS on ice then lysed in 500 ml lysis buer per plate containing 50 mM HEPES (N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulphonic acid]) pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM NaF, 50 mM phenylmethylsulphonyl¯uoride, 10 mM bglycerophosphate, 0.1 mM sodium orthovanadate, 10 mg/ml leupeptin, 10 mg/ml pepstatin A, 10 mg/ml aprotinin. Cells were scraped into microcentrifuge tubes, frozen rapidly on dry ice then thawed on ice for l h. Lysates were spun for 15 min at 48C and the supernatant assayed for protein concentration using the micro BCA protein assay (Pierce). Aliquots containing 500 mg of protein were stored at 7708C. Lysates were thawed on ice then pre cleared with 50 ml of a 50% slurry of protein A sepharose (Sigma, Product code P-3391) in lysis buer for 1 h rolling at 48C. The protein A sepharose was pelleted by a 10 s spin and the supernatant was incubated with 5 ml of antibody able to recognize cyclin E (M-20) or CDK2 (M2) (Santa Cruz Biotechnology) or 1 ml of antibody able to recognise cyclin A (clone E67, Serotec) or control puri®ed rabbit or mouse IgG (Sigma, Product codes I-8140 or M-5284 respectively). After 1 h rolling at 48C 50 ml of a 50% slurry of protein A in lysis buer was added and the lysate was rolled for a further 1 h at 48C. For mouse primary antibodies protein A sepharose was prebound with 50 ml rabbit anti-mouse IgG (Sigma, Product code M-7023) for 1 h at 48C. (Unbound IgG was removed by three washes in lysis buer). Protein A sepharose beads were pelleted with a brief spin (10 s). Beads were washed on ice three times with lysis buer and twice with kinase buer (50 mM HEPES pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 1 mM DTT). Then 20 ml of reaction buer (50 mg/ml histone H1 (Upstate Biotechnology), 10 mM ATP, 0.1 mM protein kinase A inhibitor (Sigma, Product code P-0300), 10 mCi [g-32 P]ATP in kinase buer) was added and tubes were incubated at 308C for 30 min. Reactions were stopped by addition of 26SDS gel loading buer and boiled for 10 min. Products were separated by 10% polyacrylamide gel electrophoresis. The gel was ®xed for 10 min in 10% acetic acid, 10% methanol and dried prior to autoradiography.
